Related Experiment Videos

New issues in bacterial meningitis in adults. Antibiotic resistance has complicated treatment

David H Spach1

  • 1Division of Infectious Diseases, University of Washington School of Medicine, Seattle, WA 98104, USA. spach@u.washington.edu

Postgraduate Medicine
|December 3, 2003
PubMed

Insights

Epidemiologic factors of bacterial meningitis have changed, with multidrug-resistant Streptococcus pneumoniae posing a significant challenge. This article reviews updated diagnosis, treatment, and prevention strategies for bacterial meningitis in adults.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Microbiology

Background:

  • Bacterial meningitis epidemiology has evolved significantly over 25 years.
  • Multidrug-resistant Streptococcus pneumoniae presents a major clinical challenge in managing bacterial meningitis.
  • Empirical treatment of bacterial meningitis is complicated by evolving resistance patterns.

Purpose of the Study:

  • To review new issues in the epidemiologic factors of bacterial meningitis in adults.
  • To discuss advancements in the diagnosis of bacterial meningitis.
  • To outline current treatment and prevention strategies for adult bacterial meningitis.

Main Methods:

  • Literature review of recent studies on bacterial meningitis.
  • Analysis of epidemiologic trends and antimicrobial resistance patterns.
  • Synthesis of current clinical guidelines for diagnosis, treatment, and prevention.

Main Results:

  • Emergence of multidrug-resistant Streptococcus pneumoniae as a key pathogen.
  • Changes in the epidemiology of bacterial meningitis necessitate updated management approaches.
  • Improved diagnostic tools and therapeutic options are becoming available.

Conclusions:

  • Bacterial meningitis management requires continuous adaptation to evolving epidemiologic factors and resistance.
  • Prompt and accurate diagnosis is crucial for effective treatment of bacterial meningitis.
  • Prevention strategies, including vaccination and public health measures, are vital.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...